Intervention

suvorexant

ClinicalTrials.gov intervention label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov intervention label, found in 3 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials3

Recruiting0

Common conditions5

Lead sponsors shown3

Clinical trials

3 shown

A Six Week, Randomized, Double-Blind Placebo-Controlled, Suvorexant Augmentation Study of Antidepressant Treatment of Major Depressive Disorder With Residual InsomniaNCT02669030 · 2017-03-01

UNKNOWN

To Compare the Effectiveness of Suvorexant vs Placebo on Sleep Pressure in Hypertensives With InsomniaNCT02849184 · 2017-01-17

COMPLETED

Effects of Suvorexant in Patients With Chronic Obstructive Pulmonary Disease (MK-4305-032)NCT01293006 · 2011-03-25

COMPLETED

Common conditions

Insomnia3 Depression1 Hypertension1 Major Depressive Disorder1 MDD1

Leading sponsors

Institute for Advanced Medical Research, Alpharetta, GA 1 Jichi Medical University 1 Merck Sharp & Dohme LLC 1

Trial status mix

COMPLETED2

UNKNOWN1

Phase mix

PHASE42

PHASE11

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.